Company intelligence / Profile preview

Nanovi

Ownership: Private
Development stage: Other

Overview

Nanovi has developed and commercialized a patented biomaterial platform used to create liquid fiducial markers that enhance target visibility during image-guided high precision radiation therapy. Their lead product, BioXmark®, improves accuracy in cancer radiation therapy by enabling better imaging of soft tissue targets. PetXmark™ serves a similar function in veterinary medicine. Both products are derived from an in-house developed biomaterial technology co-invented with the Technical University of Denmark[1].

Therapeutic areas: Oncology
Modalities: DeviceBiomaterial-based marker (liquid fiducial marker)
Industry: Medical Imaging

Drug pipeline

2 assets

BioXmark

Commercial

Indications: Cancer (general), Rectal cancer, High-precision radiation therapy, Proton beam therapy

1 more asset in the full pipeline.

Request access →

Partnerships

Department of Health Technology at the Technical University of Denmark, DTU (co-inventor/collaborator on biomaterial platform)

Beyond the preview

Go deeper on Nanovi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanovi.

Explore the full profile